18.4: An Overview of Amino Acid Metabolism and the Role of Cofactors

Search Fundamentals of Biochemistry

Learning Goals (ChatGPT o3-mini)

• Classify Amino Acids by Their Degradation Products:
  • Identify which amino acids are purely glucogenic, purely ketogenic, or both, and explain the structural features that determine these classifications.
  • Compare the carbon skeleton fate (conversion to pyruvate, acetyl-CoA, or TCA intermediates) with respect to the number of carbon atoms in the amino acid side chains.

• Trace the Metabolic Fate of Carbon Skeletons:
  • Describe how deaminated amino acid carbon skeletons enter central metabolic pathways such as glycolysis and the TCA cycle.
  • Explain the concepts of anaplerotic reactions and how certain amino acids replenish TCA intermediates to support biosynthesis.

• Understand Energy Production and Biosynthesis Integration:
  • Evaluate how the breakdown of amino acids contributes to both energy production and the synthesis of new biomolecules.
  • Discuss the metabolic rationale behind why acetyl-CoA generated from amino acid degradation is ketogenic rather than glucogenic.

• Examine the Role of Cofactors in Amino Acid Catabolism:
  • Identify key cofactors (e.g., pyridoxal phosphate, NAD(P)+/NAD(P)H, tetrahydrofolate, and S-adenosylmethionine) and their roles in facilitating amino acid degradation reactions.
  • Analyze the importance of cofactors in stabilizing transition states, mediating electron flow, and transferring one-carbon units during catabolic reactions.

• Explore One-Carbon (1C) Metabolism and Folate Chemistry:
  • Explain how tetrahydrofolate (FH4) and its derivatives serve as carriers for one-carbon units in various oxidation states.
  • Describe the interconversion of FH4 derivatives and the role these reactions play in both nucleotide synthesis and amino acid metabolism.

• Integrate the Methionine Cycle and SGOC Metabolism:
  • Illustrate how methyl groups are transferred from N5-methyl FH4 to form methylcobalamin and then to homocysteine, culminating in methionine synthesis.
  • Understand the significance of the Serine Glycine One Carbon (SGOC) cycle in coordinating amino acid metabolism with anabolic processes, particularly in rapidly proliferating cells.

• Connect Metabolic Pathways to Physiological and Clinical Contexts:
  • Evaluate how alterations in amino acid degradation and one-carbon metabolism can affect overall metabolic homeostasis and lead to clinical conditions (e.g., megaloblastic anemia resulting from vitamin B12 deficiency).
  • Discuss the broader metabolic interconnections that minimize waste and maximize energy extraction from amino acids, reinforcing the concept of metabolic integration.

These learning goals are intended to help students not only memorize pathways and enzyme functions but also develop a deep, integrated understanding of how amino acid catabolism interlinks with other metabolic processes and its broader physiological significance.

Amino acid degradation

In the previous chapter, we saw how nitrogen is removed from amino acids to produce urea or NH₄⁺. What are the fates of the remaining carbon skeletons? This section is where students might get overwhelmed by the diversity of amino acid degradation pathways, so it helps to realize that the carbon skeletons of deaminated amino acids can be used for biosynthesis or energy production and are converted to key glycolytic and TCA intermediates that you have seen many times before. Everything is interconnected, which makes the study of metabolism both daunting and fascinating, as organisms strive to extract all the energy and molecule-building atoms from a metabolite while minimizing waste.

Here are some key features of amino acid catabolism:

• some are converted to pyruvate, the end product of glycolysis and the start reactant of gluconeogenesis. Hence, these amino acids are glucogenic.
• some are converted to acetoacetyl-CoA and or acetyl-CoA. Both can be converted to ketone bodies (acetoacetate/β-hydroxybutyrate), which are considered ketogenic. Since the two carbons of the acetyl group of acetyl-CoA are lost as CO₂ in the TCA cycle, and there is no reverse for the pyruvate dehydrogenase reaction (pyr → acetyl-CoA), acetyl-CoA formed by amino acid degradation can not be used to create glucose in a net fashion.
• some are metabolized to form TCA intermediates. Since they are added in a net fashion to the TCA cycle and don't remove the existing pool of TCA intermediates, they can produce, in a net fashion, directly or indirectly, molecules that can be used to produce glucose. These entry reactions to the TCA, which replenish or add to TCA intermediates, are called anaplerotic (replenishing) reactions. Hence, these amino acids are also glucogenic.
• some have multiple ways to be degraded and can produce both acetyl-CoA and pyruvate, so they are both glucogenic and ketogenic.

Let's get more explicit:

• purely ketogenic: only Leu and Lys (the only amino acids whose name starts with L, and you have to Love them since there are only two amino acids in this category)
• both: 5 including the aromatics - Trp, Tyr, Phe - and Ile/Thr
• purely glucogenic: the rest

General hints if an amino acid is glucogenic and/or ketogenic are derived from its structure.

Fully or Partly Ketogenic Amino Acids: Amino acids, except for Arg, that have a continuous chain of 3 or more carbon atoms in their side chains and hence are more "fat-like" are ketogenic or ketogenic/glucogenic. These include Lys, Leu, Ile, and the aromatic amino acids Phe, Trp, and Tyr, excluding Val. (note: Thr, both ketogenic and glucogenic, doesn't fit this rule). The wholly or partly ketogenic amino acids are shown in Figure \(\PageIndex{1}\).

Figure \(\PageIndex{1}\): Fully or Partly Ketogenic Amino Acids

Purely Glucogenic Amino Acids (for Pyr and/or TCA intermediates): Which amino acids produce which intermediate? Except for glycine, it's pretty easy to remember. The number of carbons in the intermediate formed is the same as the number of carbons in the longest chain in the amino acid.

These amino acids form the 5C TCA intermediate alpha-ketoglutarate (2-oxoglutarate) and are shown in Figure \(\PageIndex{2}\).

Figure \(\PageIndex{2}\): Glucogenic Amino Acids Converted to 5C α-ketoglutarate (2-oxoglutarate)

These amino acids form either the 4C TCA intermediate succinate or oxaloacetate. Amino acids with more oxidized 4C atoms in the continuous chain produced oxaloacetate (which is more oxidized than succinate), while the least oxidized ones produced succinic acid (which is more reduced than oxaloacetate). These amino acids are shown in Figure \(\PageIndex{3}\).

Figure \(\PageIndex{3}\): Glucogenic Amino Acids Converted to 4C oxaloacetate and succinate

The 3C amino acids, Ser, Ala, and Cys, form pyruvate, as shown in Figure \(\PageIndex{4}\).  The only 2C amino acid, glycine, does as well.

Figure \(\PageIndex{4}\): Glucogenic Amino Acids Converted to 3C pyruvate

A full figure summarizing everything above is shown in Figure \(\PageIndex{5}\)!

Figure \(\PageIndex{5}\): Summary of amino acid breakdown products

With a little help from my friends: Cofactors and Amino Acid Catabolism

The myriad of breaking, making, and rearranging carbon atoms in amino acid catabolism is daunting. As with all reactions, a pathway for a flow of electrons and stabilization of transition states and intermediates must be in place for the reactions to occur. All methods of catalysis (general acid/base, covalent/nucleophilic, electrostatic/metal ion, and preferential stabilization of the transition state) occur. Yet some reactions need additional "helpers" or "cofactors" to facilitate electron flow and shuttle small motifs (from electrons in redox reactions to methyl groups in methylases) from one molecule to another. In the previous section, we've seen the important role of pyridoxal phosphate in transaminations/aminotransferases. Even the terminology cofactor is a bit confusing since analogous terms are used in different contexts:

• cofactors - nonprotein small molecules or ions (divalent ions, transition metal ions, and Fe/S clusters, for example) that must bind to an enzyme but usually stay put once bound. That is, they don't dissociate during the catalytic cycle. For instance, PLP must initially bind to an enzyme but then becomes covalently attached through a Schiff base through the epsilon amino group of a Lys in the catalytic site. For example, that linkage might be swapped with an incoming amino acid substrate but reform in the catalytic cycle, allowing the enzyme to remain functional.
• coenzyme - a vitamin derivative, organic cofactor, as compared to inorganic ions. Coenzyme is a poor historical name that persists.
• prosthetic group - this is usually a coenzyme that is either covalently bound (like PLP) or noncovalently bound with such a low K_D (like FAD/FADH₂-containing enzymes) that they stay bound
• cosubstrate - these bind as substrate (for example, NAD⁺), and depart as products (for example, NADH).

Here is a table of common nonmetallic cofactors.

Cofactor	Vitamin Derivative	Carrier
biotin	H - biotin	1 C - CO2 (most oxidized)
tetrahydrofolic acid (FH4 or THF)	B9 - folic acid	1C - formyl, -(C=O)H, methylene (-CH2) (more reduced) and methyl -CH3
cobalamin	B12 - cobalamin	methyl CH3
thiamine pyrophosphate	B1 - Thiamine	2C group
coenzyme A	B5 - pantothenic acids	acetyl (CH3-C=O) and acyl (R-C=O)
pyridoxal phosphate	B6 - pyridoxine	amino and carboxyl groups
NAD^+/NADP^+	B3 - Niacin	electrons
FAD/FMN	B2 - riboflavin	electrons

Other non-vitamin cofactors include S-adenosylmethionine (SAM or adoMet), a carrier of methyl groups; Coenzyme Q, a carrier of electrons; tetrahydrobiopterin, a carrier of oxygen and electrons; and heme, a carrier of electrons.

We've already described amino acid deamination reactions using PLP. Now let's consider the biochemistry of two of these cofactors involved in 1 C transfers in amino acid metabolism in more detail, tetrahydrofolate (FH₄) and SAM.

Tetrahydrofolate (FH₄)

Tetrahydrofolate (FH₄) is a key cofactor in the metabolism of amino acids and the biosynthesis of nucleotides. It is also commonly abbreviated as THF, especially in the names of enzymes that use it. To avoid confusion with chemists' use of THF for tetrahydrofuran, it will be referred to mostly here as FH_4; however, the enzymes will be named as derivatives of the abbreviation XHF (X = D for dihydro and T for tetrahydro).

FH₄ is a carrier of 1 C units in various oxidation states. It receives 1C units and then transfers them to other species. The structure of FH₄ and derivatives carrying 1 C units with different oxidation numbers (indicating their oxidation state) are shown in Figure \(\PageIndex{6}\).

Figure \(\PageIndex{6}\): 1C derivatives in different oxidation states for tetrahydrofolate

FH₄ is made from the vitamin folate (bacteria, fungi, and most plants can synthesize it), which is first converted to dihydrofolate (FH₂) and then tetrahydrofolate (FH₄) by the enzyme dihydrofolate reductase, using NADPH as a reducing substrate "cofactor." The model below depicts this small enzyme complexed with NADPH (NADP⁺), folate, and DHFR (7dfr). Folate (FOL) is shown in salmon space fill, while NADPH is shown in cyan.

Figure \(\PageIndex{7}\) shows an interactive iCn3D model of dihydrofolate reductase with bound NADPH (NADP⁺) and folate (7dfr).

Figure \(\PageIndex{7}\): Dihydrofolate reductase with bound NADP⁺ and folate (7dfr). (Copyright; author via source). Click the image for a popup or use this external link: https://structure.ncbi.nlm.nih.gov/i...ojdpBZuQH8Lm96

Folate (FOL) and NADP⁺ (NAP) are shown in spacefill and CPK colors. The side chain of Asp 27 is shown in sticks and CPK colors. The oxygen atoms of two water molecules interacting with folate are shown as red spheres. A disordered and, hence, mobile loop (residues 16-20) that binds the nicotinamide is shown in cyan.​

As FH₄ is a key substrate in many reactions, including nucleotide synthesis (as we shall see later), this enzyme is a key target for chemotherapy to kill cancer cells, which require robust nucleotide synthesis for rapid cell proliferation. One such drug, which inhibits the enzyme, methotrexate, is shown in Figure \(\PageIndex{8}\).

Figure \(\PageIndex{8}\): A structural comparison of the chemotherapeutic drug methotrexate and folate

Before getting into the nitty-gritty of amino acid degradation and tetrahydrofolate chemistry, let's take a look at the mechanism by which dihydrofolate reductase, DHFR, catalyzes the sequential reduction by 2 NADPH molecules of folate to tetrahydrofolate. This is illustrated in Figure \(\PageIndex{9}\).

Figure \(\PageIndex{9}\): Conversion of folate to tetrahydrofolate by dihydrofolate reductase

One Carbon Chemistry: The Interconversion of FH₄ 1C derivatives

Tetrahydrofolate is a carrier for 1C units in metabolism. As such, it is intimately involved in many anabolic and catabolic reactions. These include thymidine and purine biosynthesis and amino acid metabolism through reactions involving serine, glycine (both with 1C in their side chains), and methionine (with 1C after the sulfur in the side chain). Reactions occur in both the cytoplasm and mitochondria. FH₄ is involved directly or indirectly in the epigenetic control of DNA expression, as methylation of both DNA and histones is critical to gene expression. The myriad of 1C derivatives of FH₄ makes the biochemistry complex.  Since the transfer of 1C is a critical job in the breakdown of amino acids' carbon skeleton and biosynthesis, we need to explore it. The complexity is simplified by noting that the 1C derivatives have only three different oxidation states (+2, 0, and -2), as noted in Figure \(\PageIndex{10}\).

Figure \(\PageIndex{10}\): Interconversion of 1C derivatives of tetrahydrofolate. The oxidation number of the 1C addition is shown in red. (after http://education.med.nyu.edu/mbm/aminoAcids/folate.shtml)

1C units usually enter FH₄ as the N⁵,N¹⁰ methylene unit. This is made in the cytoplasm and mitochondria since 1C-derivatized FH₄ appears not to cross the mitochondrial membranes. The methylene derivative (with a 1C oxidation # = 0) can be reduced to form methyl (oxidation # -2) or oxidized to methenyl or formyl groups (oxidation # +2).

We will revisit some of these reactions in chapters that deal with amino acid and nucleotide biosynthesis. That's not a bad thing—learning occurs best when material is repeated in different contexts.

Methylcobalamin and ⁵N-methyl FH₄

Methyl groups can be stored and transferred from ⁵N-methyl FH₄ to another cofactor, cobalamine, to form methylcobalamin (Vitamin B12).  The -CH₃ can then be transferred to homocysteine  (the side chain is the same as for Cys but with one extra -CH₂ methylene group) to form methionine.  This adds to the complexity of 1C transfer, but the iCn3D models below should help you to differentiate the chemical structures of each.

Here is a model of methylcobalamin (vitamin B12) in ball-and-stick form.

Note that the -CH₃ is connected to the center cobalt in the macrocyclic ring.

In contrast, here is the structure of N⁵-methyl FH₄.

The -CH₃ here is connected to a ring N5 of FH₄.

Serine Hydroxymethyltransferase (SHMT): A complex reaction needs two cofactors - PLP and FH₄

Let's examine one mechanism that illustrates how a 1C methylene is added to tetrahydrofolate (FH₄). The mechanism shown is for serine dehydratase, also known as serine hydroxymethyltransferase. The enzyme not only uses tetrahydrofolate as a substrate but also PLP, which, as we have seen previously, forms bonds to the alpha-carbon of amino acids that are labile to cleavage. In this case, the amino acid serine dehydrates through an alpha-elimination reaction. Here is the overall reaction.

Serine + FH₄ ↔ Glycine + N⁵,N¹⁰-CH₂-FH₄ + H₂O

Figure \(\PageIndex{11}\) shows the dehydration reaction and formation of glycine, using PLP as a cofactor. Figure B shows how the released formaldehyde reacts with FH₄ to form N⁵,N¹⁰-methylene FH4, using FH₄ as a cofactor. As this is needed in purine and thymidylate synthesis, SHMT is also a target for malaria treatment.

Figure \(\PageIndex{11}\): Serine hydroxymethyltransferase reaction mechanism

Glu 57 plays a key role as a general acid/base throughout the catalytic cycle of the enzyme.

Pathway diagrams showing a myriad of reactants, products, and enzymes can be very confusing. It's helpful to think about them and see them in different ways. Here is another way to present the conversion of FH₄ and its various 1C intermediates. Figure \(\PageIndex{12}\) concentrates on the outputs of 1C FH₄ derivatives (shown in blue eclipses).

Figure \(\PageIndex{12}\): Folate 1C Metabolism - Cyclic Presentation after Ducker and Rabinowitz, Cell Metab. 2017 January 10; 25(1): 27–42. doi:10.1016/j.cmet.2016.08.009

The enzymes catalyzing these reactions are shown in the table below. This figure applies to both catabolic and anabolic reactions using FH₄ derivatives. Oxidation numbers for the 1C adducts are shown. Any reaction that changes the redox state must use NAD(P)⁺/NAD(P)H as a redox reagent.

• N⁵,N¹⁰-methylene FH₄ gives thymidine and serine
• N⁵-methyl FH₄ gives methionine
• N¹⁰-formyl FH₄ gives formate, purines, and CO₂
• N⁵-formyl serves more as a passive reservoir of 1C units.

Table \(\PageIndex{1}\): Enzymes catalyzing interconversions of THF derivatives

Abbreviation	Enzyme Name
ALDH	10-formyltetrahydrofolate((aldehyde) dehydrogenase.
DHFR	Dihydrofolate reductase
MTHFD	methylenetetrahydrofolate dehydrogenase
MTHFD1	C-1-tetrahydrofolate synthase, cytoplasmic
MTHFD1L	monofunctional tetrahydrofolate synthase, mitochondrial
MTHFD2/L	methylenetetrahydrofolate dehydrogenase 2/2-like
MTFMT	mitochondrial methionyl-tRNA formyltransferase
MTHFR	methylenetetrahydrofolate reductase
MTR	methionine synthase
TYMS	thymidylate synthetase

A key enzyme in these reactions, methylene-THF reductase (MTHFR), irreversibly removes 1C from the cycle depicted above as it forms N⁵-methyl FH₄. As this reaction is a reduction, it requires a reducing agent (NADPH in yeast and animals and NADH in plants). As we will see next, this irreversible removal would deplete the cycle shown; therefore, it is allosterically regulated (inhibited) by another methylating agent, S-adenosylmethionine (SAM, also known as adoMet). Plant versions of the enzyme are reversible, so SAM does not need to regulate them in this feedback loop process.

S-adenosylmethionine (SAM), also known as adoMet

N⁵-methyl FH₄ appears to have one function: to methylate a molecule called homocysteine (same as Cys but with an extra -CH₂ in the side chain) to methionine. This is adenosylated (not phosphorylated!) with ATP to produce S-adenosylmethionine (SAM), a more potent methylating agent than N⁵-methyl FH₄. SAM is, hence, part of a cycle involving N5-methyl-FH4. The methyl group of N⁵-methyl FH₄ reacts with homocysteine to produce methionine, catalyzed by the enzyme methionine synthase, which requires cobalamin (vitamin B12) as a cofactor. The combined Figure \(\PageIndex{13}\) adds the Met and Folate cycles (showing the outputs of the 1C Folate metabolism cycle.

Figure \(\PageIndex{13}\): Folate and Methionine Cycle (after Ducker and Rabinowitz, Cell Metab. 2017 Jan 10; 25(1): 27–42.)

Figure \(\PageIndex{14}\) shows the structures of molecules in the Met Cycle.

Figure \(\PageIndex{14}\): The Met Cycle and Methylations by SAM

The mechanism of methyl transfers using SAM as the -CH₃ donor involves an SN₂ attack by a nucleophile of the substrate on the CH₃ of SAM, with the electron pair from the C-S bond going to the positively charged sulfonium sulfur, a great "electron sink". An analogous nucleophilic attack on the terminal CH₃ of plain old methionine would not be readily enabled. Hence, SAM, with its charged S, has a much higher methyl transfer potential than N⁵-CH₃-FH₄.

In the actual reaction catalyzed by methionine synthase (MS) in mammals, the methyl-CH₃ from N⁵-methyl FH₄ is first transferred to cobalamin, a derivative of vitamin B12, to form methylcobalamin, which then transfers it to homocysteine. The structure of the C-terminal half of B₁₂-dependent Methionine Synthase from E. Coli with bound adenosylhomocysteine (3iva) is shown below and in this link:

Figure \(\PageIndex{15}\) shows an interactive iCn3D model of the C-terminal half of B₁₂-dependent Methionine Synthase from E. Coli with bound adenosylhomocysteine bound (3iva)

Figure \(\PageIndex{15}\): C-terminal half of B₁₂-dependent Methionine Synthase from E. Coli with bound adenosylhomocysteine (3iva). (Copyright; author via source). Click the image for a popup or use this external link: https://structure.ncbi.nlm.nih.gov/i...E7jTsdvVvx1M1A

In mammals, vitamin B₁₂ is a key cofactor in only two enzymes.  One is methionine synthase. The other catalyzes the conversion of methylmalonyl-CoA (derived from the metabolism of Ile, Thr, Val, and Met (as we will see in the next chapter section) to succinyl-CoA in the citric acid cycle. If vitamin B₁₂ is lacking, N⁵-methyl FH₄ builds up when it can't be transferred to cobalamin to form methylcobalamin, the direct methylating agent in methionine synthesis catalyzed by methionine synthase.  Hence, homocysteine builds up as it can't form methionine. Since the enzyme that converts N⁵,N¹⁰-methylene FH₄ to N⁵-methyl FH₄, methylenetetrahydrofolate reductase (MTHFR), is irreversible, levels of N⁵-methyl FH₄ are high. You can view N⁵-methyl FH₄ as a storage form of folate, so if there is a lack of B12, the use of this storage form of folate becomes impaired.  The results of B12 deficiency include megaloblastic anemia.

The Serine Glycine One Carbon (SGOC) Metabolic Cycle

Figure 12 illustrates the coupled Folate and Methionine cycles, highlighting the intermediates involved in the 1C-CH₃ transfer reaction, a crucial aspect of amino acid metabolism and other anabolic and catabolic processes. Interpreting metabolic figures is complicated. Each is designed to emphasize certain selected features. Another way to present Figure 12 is to emphasize the metabolites involved in 1C chemistry. Figure \(\PageIndex{145}\) shows what has been called the Serine Glycine One Carbon (SGOC) metabolic cycle. It is simply a redrawn version of Figure 12, with attention drawn to non-FH4 molecules involved in 1C transfers, specifically serine, glycine, and formate.

Figure \(\PageIndex{15}\): The Ser-Gly One Carbon (SGOC) Cycle

This cycle, along with its key substrates serine and glycine, integrates numerous metabolic pathways and regulates the conversion of serine and glycine into essential outputs for other pathways. We will see this cycle again in the chapter on the biosynthesis of amino acids. The pathway is especially important in tumor cells, which need precursors for nucleic acid, protein, and lipid synthesis.

Summary

Amino acid degradation not only provides a mechanism to dispose of excess nitrogen (via urea or direct NH₄⁺ excretion) but also channels the remaining carbon skeletons into central metabolic pathways. This chapter explores how deaminated carbon skeletons are converted into key intermediates for energy production and biosynthesis, emphasizing the following core concepts:

Fates of Carbon Skeletons:

• Glucogenic Pathways:
  Many amino acids are broken down into intermediates such as pyruvate, oxaloacetate, succinate, or α-ketoglutarate, which can enter the TCA cycle. These pathways can ultimately contribute to gluconeogenesis, replenishing blood glucose levels.
• Ketogenic Pathways:
  A smaller subset of amino acids (notably leucine and lysine) is converted to acetyl-CoA or acetoacetyl-CoA. These intermediates can be used to form ketone bodies, since acetyl-CoA’s carbons are lost as CO₂ in the TCA cycle and cannot be net used for gluconeogenesis.
• Dual Role Amino Acids:
  Some amino acids can give rise to both glucogenic and ketogenic products, reflecting their diverse metabolic fates.

Structural Determinants:
Amino acids with longer, continuous carbon chains in their side groups tend to be ketogenic or both, while those yielding intermediates with the same carbon number as their longest chain tend to be glucogenic. These distinctions are crucial for understanding metabolic flexibility and energy extraction.

Role of Cofactors in Catabolism:
Enzyme-catalyzed degradation of amino acids relies on various cofactors that:

• Stabilize Transition States: For example, pyridoxal phosphate (PLP) is essential in transamination reactions.
• Mediate Electron and Group Transfers: NAD(P)⁺/NAD(P)H, as well as other cofactors like coenzyme A, are critical for oxidation–reduction and acyl group transfers during the breakdown of carbon skeletons.

One-Carbon Metabolism and Folate Chemistry:
The chapter delves into the importance of one-carbon (1C) transfers, primarily mediated by tetrahydrofolate (FH₄) and its derivatives:

• Diverse 1C Forms: FH₄ can carry one-carbon units in various oxidation states (e.g., methylene, methyl, formyl), which are central to both nucleotide biosynthesis and amino acid metabolism.
• Interconnected Cycles: The interconversion between FH₄ derivatives underpins the folate and methionine cycles. For instance, the conversion of N5,N10-methylene FH₄ to N5-methyl FH₄ is an irreversible step catalyzed by methylenetetrahydrofolate reductase (MTHFR) and is tightly regulated.
• Methyl Group Transfer: Methylcobalamin (a derivative of vitamin B₁₂) plays a crucial role in transferring methyl groups from N5-methyl FH₄ to homocysteine, thereby generating methionine. This interrelationship is central to epigenetic regulation and metabolic control.

The Serine Glycine One-Carbon (SGOC) Cycle:
An emerging concept discussed is the SGOC cycle, which integrates serine and glycine metabolism with 1C transfers. This cycle is pivotal not only for maintaining nucleotide pools and redox balance but also for supporting the anabolic demands of rapidly proliferating cells, such as those found in tumors.

Overall Integration and Physiological Impact:
The degradation of amino acids illustrates the broader theme of metabolic integration—how the body efficiently recycles carbon skeletons for energy and biosynthesis while ensuring minimal waste. These pathways, their regulation by cofactors, and the integration of 1C metabolism underscore the elegance and complexity of metabolic control, with direct implications for understanding metabolic disorders and therapeutic interventions (e.g., targeting DHFR in cancer chemotherapy).

In summary, this chapter provides a comprehensive look at how amino acid catabolism is interwoven with central metabolic pathways, emphasizing the structural, enzymatic, and regulatory mechanisms that govern the fate of carbon skeletons and one-carbon units in cellular metabolism.